Japan's Fujifilm to spend US$928m to double capacity of Danish drug facility | Malay Mail

Friday, 12 Jun 2020 10:31 AM MYT

TOKYO, June 12 ― Fujifilm Holdings Corp will spend US$928 million to double capacity at a drug manufacturing facility in Denmark, which it has pledged to use in producing Covid-19 treatments, as the Japanese company steps up its pivot towards healthcare. The investment expands Fujifilm's presence as a global contract development and manufacturing organisation , which supplies other companies in the pharma industry. Fujifilm started to diversify from cameras and office equipment and into healthcare more than a decade ago.

Business Business Latest News, Business Business Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Japan’s AnGes speeds towards 2021 rollout in coronavirus ‘vaccine war’ | Malay MailOSAKA, June 10 — Japanese biotech AnGes Inc expects its coronavirus vaccine to be ready as early as the first half of 2021, if it can overcome supply chain and production hurdles, the company’s founder said. The Osaka-based firm had a headstart in the potential Covid-19 vaccine development by...
Source: malaymail - 🏆 1. / 86 Read more »